We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
1-Year Est. Return
41.24%
This Quarter
Est. Return
+3.88%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$56.7B
AUM Growth
+$8.88B
(+19%)
Cap. Flow
+$7.92B
Cap. Flow
% of AUM
13.98%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
2,107
New
102
Increased
1,467
Reduced
463
Closed
73
Avg Time Held
24
quarters
Top 10 Avg Time Held
22.8
quarters
Top 20 Avg Time Held
20.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$779M |
| 2 |
Apple
AAPL
|
+$539M |
| 3 |
Microsoft
MSFT
|
+$522M |
| 4 |
Meta Platforms (Facebook)
META
|
+$487M |
| 5 |
Tesla
TSLA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$189M |
| 2 |
C.H. Robinson
CHRW
|
+$55.4M |
| 3 |
Fortinet
FTNT
|
+$55M |
| 4 |
AbbVie
ABBV
|
+$35.7M |
| 5 |
NextEra Energy
NEE
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Communication Services | 10.74% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Industrials | 8.58% |
| 5 | Consumer Staples | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1751
Upbound Group
UPBD
$898M
| $179K | ﹤0.01% |
10,205
+317
| +3% | +$6.13K |
2023 Q2
10 quarters
|
|
1752
NPK International
NPKI
$959M
| $178K | ﹤0.01% |
14,970
+1,542
| +11% | +$18.8K |
2023 Q4
8 quarters
|
|
1753
Monte Rosa Therapeutics
GLUE
$844M
| $178K | ﹤0.01% |
11,374
+1,199
| +12% | +$16.2K |
2024 Q4
4 quarters
|
|
1754
Graphic Packaging
GPK
$2.49B
| $178K | ﹤0.01% |
11,837
-764
| -6% | -$12.6K |
2023 Q2
10 quarters
|
|
1755
Rapid7
RPD
$871M
| $177K | ﹤0.01% |
11,666
+738
| +7% | +$12.1K |
2020 Q2
22 quarters
|
|
1756
Phreesia
PHR
$667M
| $177K | ﹤0.01% |
10,458
+670
| +7% | +$13.8K |
2024 Q3
5 quarters
|
|
1757
ARS Pharmaceuticals
SPRY
$403M
| $176K | ﹤0.01% |
15,139
+1,532
| +11% | +$14.9K |
2024 Q3
5 quarters
|
|
1758
DELISTED
Day One Biopharmaceuticals
DAWN
| $176K | ﹤0.01% |
18,895
+2,939
| +18% | +$24.6K |
2023 Q2
10 quarters
|
|
1759
Arvinas
ARVN
$447M
| $176K | ﹤0.01% |
14,827
+993
| +7% | +$10.8K |
2023 Q4
8 quarters
|
|
1760
Clover Health Investments
CLOV
$2.55B
| $176K | ﹤0.01% |
74,700
+5,660
| +8% | +$15.5K |
2025 Q2
2 quarters
|
|
1761
MFA Financial
MFA
$677M
| $175K | ﹤0.01% |
18,829
+1,211
| +7% | +$11.3K |
2013 Q2
50 quarters
|
|
1762
National Energy Services Reunited Corp
NESR
$2.12B
| $175K | ﹤0.01% |
11,148
+719
| +7% | +$9.43K |
2025 Q2
2 quarters
|
|
1763
Arbutus Biopharma
ABUS
$814M
| $174K | ﹤0.01% |
36,161
+3,446
| +11% | +$15.5K |
2020 Q4
20 quarters
|
|
1764
SFL Corp
SFL
$1.88B
| $173K | ﹤0.01% |
22,171
+1,424
| +7% | +$10.9K |
2020 Q2
22 quarters
|
|
1765
Liberty Latin America Class C
LILAK
$1.61B
| $173K | ﹤0.01% |
25,505
+1,644
| +7% | +$12.3K |
2020 Q2
22 quarters
|
|
1766
Phathom Pharmaceuticals
PHAT
$566M
| $172K | ﹤0.01% |
+10,377
| New | +$148K |
2025 Q4
0 quarters
|
|
1767
Navient
NAVI
$883M
| $172K | ﹤0.01% |
13,228
+174
| +1% | +$2.17K |
2014 Q2
46 quarters
|
|
1768
Sana Biotechnology
SANA
$721M
| $171K | ﹤0.01% |
42,126
+10,096
| +32% | +$45.2K |
2021 Q3
17 quarters
|
|
1769
Barings BDC
BBDC
$891M
| $171K | ﹤0.01% |
18,669
-1,100
| -6% | -$9.74K |
2023 Q3
9 quarters
|
|
1770
Sprinklr
CXM
$1.31B
| $171K | ﹤0.01% |
21,956
+597
| +3% | +$4.54K |
2023 Q2
10 quarters
|
|
1771
Hornbeck Offshore Services, Inc.
HOS
$2.37B
| $169K | ﹤0.01% |
27,019
+851
| +3% | +$5.66K |
2013 Q2
50 quarters
|
|
1772
Geron
GERN
$771M
| $169K | ﹤0.01% |
128,026
+11,890
| +10% | +$14.9K |
2013 Q2
50 quarters
|
|
1773
Empire State Realty Trust
ESRT
$841M
| $167K | ﹤0.01% |
25,603
+1,991
| +8% | +$14.2K |
2021 Q2
18 quarters
|
|
1774
BrightView Holdings
BV
$1B
| $166K | ﹤0.01% |
13,138
+848
| +7% | +$10.8K |
2024 Q3
5 quarters
|
|
1775
Erasca
ERAS
$5.17B
| $164K | ﹤0.01% |
44,216
+4,430
| +11% | +$12.5K |
2021 Q4
16 quarters
|
|
Similar funds
ProShare Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, ProShare Advisors held 2,107 positions worth $56.7B, up 19% from $47.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
ProShare Advisors deployed $7.92B of net new capital in Q4 2025, opening 102 new positions and adding to 1,467 existing holdings. Its largest new stake was CRH: 131,018 shares worth $16.4M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $189M trimmed.
- ProShare Advisors's largest Q4 2025 buy was CRH: 131,018 shares worth $16.4M.
- ProShare Advisors added most to NVIDIA in Q4 2025, an estimated $779M increase.
- ProShare Advisors's biggest Q4 2025 reduction was Broadcom, cutting an estimated $189M.
- ProShare Advisors fully exited Perrigo in Q4 2025, selling an estimated $27.6M.
- ProShare Advisors's ten largest holdings make up 34% of its $56.7B portfolio in Q4 2025.
- ProShare Advisors opened 102 new positions and closed 73 in Q4 2025.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $56.7B.
Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.